Gilead–U.S. Pact Aims to Cut Drug Costs for Americans
December 22, 2025 | Foster City, California — Gilead Sciences announced a three-year agreement with the U.S. Government designed...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
December 22, 2025 | Foster City, California — Gilead Sciences announced a three-year agreement with the U.S. Government designed...
December 19, 2025 | Princeton, New Jersey — Bristol Myers Squibb announced a landmark agreement with the U.S. government...
